Using Sitagliptin as a Treatment to Prevent New Onset Diabetes After Kidney Transplantation

NCT00936663 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped lack of funding

Conditions

Type 2 Diabetes
End Stage Renal Disease

Interventions

DRUG: Placebo
DRUG: Sitagliptin

Sponsor

University of Nebraska